Microval 0,03 mg Sugar-coated tablets.
PDF Leaflet Revision Date: 20 May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Control of fertility.
Dosage (summary)
One tablet daily at the same time, starting on day 1 of the menstrual cycle.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; can be used during breastfeeding after 6 weeks postpartum.
Key Drug Interactions
- Hepatic enzyme inducers
- Warfarin
- CYP3A4 inhibitors
Contraindications
- Hypersensitivity to levonorgestrel
- Known or suspected pregnancy
- Severe hepatic disease
- History of thromboembolic processes
- Depression not well controlled
Common side effects
- Uterine/vaginal bleeding
- Amenorrhea
- Migraine
- Dizziness
Counselling Points
- Take at the same time daily
- Use additional contraception if a tablet is missed
- Report any mood changes or severe headaches
Serious warnings
- Increased risk of serious cardiovascular side effects with smoking
- Discontinue if migraine becomes focal or vision is disturbed
- Does not protect against STIs
Important Disclaimer
The Microval 0,03 mg Sugar-coated tablets. professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
